What You Ought to Know:
– Certara, a worldwide chief in model-informed drug improvement, as we speak introduced an expanded collaboration with Merck, referred to as MSD outdoors of the USA and Canada.
– The strategic settlement will see Merck enhance its use of the Certara Pinnacle 21 software program platform to incorporate a metadata repository and knowledge requirements workflow administration. This builds upon Merck’s present know-how collaboration with Certara aimed toward aiding regulatory submissions.
Addressing Knowledge Standardization Challenges in Fashionable Scientific Trials
The method of remodeling uncooked knowledge into validated, analysis-ready datasets has change into more and more advanced in trendy drug improvement. This problem is amplified by the sheer quantity of knowledge collected; Part III scientific trials now common 3.6 million knowledge factors, representing a threefold enhance over the past decade.
The Certara Pinnacle 21 platform is particularly designed to resolve these knowledge standardization challenges at scale. By increasing its use of this platform, Merck goals to additional streamline its knowledge administration processes.
“We’re happy to strengthen our ongoing collaboration with Merck to help with knowledge requirements administration and to increase the worth of the Pinnacle 21 platform,” stated William F. Feehery, Chief Government Officer of Certara. He emphasised the alignment between the 2 corporations, stating, “Merck is a premier research-intensive firm, and our groups are well-aligned within the aim of delivering high-quality analysis knowledge sooner to assist save and enhance lives around the globe”.
